Asia morning update: Weak leads for Asian markets

Broadly neutral US markets and the slide in oil prices sets Asian markets on a weak starting note midweek.

Chart
Source: Bloomberg

Record highs were once again seen for both the NASDAQ and S&P 500 index, though most US markets remained largely in consolidation. Pushing up the comprehensive S&P 500 index had been the IT and financial sectors while Monday’s top gainer, the materials sector, ended the session near neutral despite the softer USD.

Matters relating to the disclosure report on President Donald Trump appear to have snowballed with the latest involvement of Israel intelligence, capping gains for the broader US market. The political development could certainly be an unwelcoming distraction for a market waiting for further policy updates from the new administration.

While equity markets were seen trending in a sideway manner, the key move for the overnight market had been the slide in the US dollar. The dollar index had further slipped to trade just above the 98.0 figure into Wednesday morning with EUR/USD bumping down the overall index. Both politics and economic data could be seen driving this move overnight.

Specifically, the highly watched housing starts had disappointed markets, something which the improvement in industrial production could do little to cushion. The pressure for EUR/USD had also been rather pronounced, driven by the diverging trend in data performance between the US and Europe. A generally positive set of economic data have appeared to boost sentiment for EUR bulls.

Early morning data arrived from Japan and Singapore, both missing market expectations and creating further downward pressure for the respective markets. Notably, Singapore’s April non-oil domestic exports (NODX) had declined 0.7% year-on-year (YoY) despite expectations for the headline figure to moderate only slightly from the 16.5% YoY growth in March. A breakdown of the components finds that while electronics exports slowed, the main drag had been brought about by a sharp reversal in pharmaceuticals export growth. For the local STI, the first decline in NODX in four months could mean further jitters after the heavy sell-off on Tuesday.

Sharp declines have already been registered on both the Japan and Australian markets this morning, with the Nikkei 225 affected by the USD/JPY drop. Pressure from the reversal in crude prices is also expected to hold down regional bourses midweek. For the day ahead, there remains Malaysia’s inflation data and Japan’s industrial production due in Asian hours, though traders could find the Eurozone’s inflation rate of higher interest.

Yesterday: S&P 500 -0.07%; DJIA -0.01%; DAX -0.02%; FTSE +0.91%

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.